EUVIMEDObjevte EUVIMED
Crossref

First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study

Catalina De Paco Matallana iD, Javier Sánchez Romero iD, Miriam Pertegal iD, Juan Luis Delgado iD, Erica Ramfjord, Kypros H Nicolaides

Prenatal Diagnosis · 2026

DOI: 10.1002/pd.70260 ↗

At a glance

Journal article in Prenatal Diagnosis, 2026. Written by Catalina De Paco Matallana and 5 co-authors. Institution: Department of Obstetrics and Gynecology, "Virgen de la Arrixaca" University Hospital, Murcia, Spain. Major MEDLINE topics: Pregnancy Trimester, First, Cell-Free Nucleic Acids, Trisomy. 32 references. Funded by: Partial funding for this study was provided by Vanadis Diagnostics AB, a Revvity Inc. company, through the Foundation for Health Research and Training in the R….

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

To evaluate cell‐free DNA screening for trisomies 21, 18 and 13 using rolling circle replication in an unselected routine first‐trimester screening population.

Method

This study enrolled 3025 women undergoing first‐trimester screening. Excluding unavailable samples, missing outcome data, pregnancy loss and twin gestation, 2729 pregnancies with follow‐up remained; 2689 had cell‐free DNA results for performance analysis. Cell‐free fetal DNA was assessed by rolling circle replication and digital fluorescence detection without PCR or sequencing. Performance was confirmed with cytogenetic results or postnatal outcomes.

Results

Among 2729 eligible singleton pregnancies with follow‐up, valid cfDNA results were obtained in 2689 cases, corresponding to an overall no‐call rate of 40/2729 (1.47%). For trisomy 21, sensitivity was 14/14 (100%; 95% CI, 76.8–100), specificity was 2666/2675 (99.7%; 95% CI, 99.4–99.8), and PPV was 14/23 (60.9%; 95% CI, 38.5–80.3). For trisomy 18, sensitivity was 1/2 (50.0%; 95% CI, 1.3–98.7), specificity was 2681/2687 (99.8%; 95% CI, 99.5–99.9), and PPV was 1/7 (14.3%; 95% CI, 0.4–57.9). No confirmed trisomy 13 cases were observed. Fetal sex was correctly assigned in 2657/2688 cases (98.8%). Testing before 10 weeks' gestation and in IVF pregnancies appeared technically feasible, but these subgroup findings were limited by small numbers.

Conclusions

Rolling circle replication‐based cell‐free DNA screening showed high accuracy for trisomy 21 and fetal sex determination in this unselected routine first‐trimester screening population. However, the small number of trisomy 18 and trisomy 13 cases limits conclusions for these aneuploidies.

Subjects

MeSH terms (MEDLINE)

Pregnancy Trimester, FirstCell-Free Nucleic AcidsTrisomyHumansFemalePregnancyProspective StudiesAdultTrisomy 18 SyndromeSensitivity and SpecificityNucleic Acid Amplification TechniquesTrisomy 13 SyndromeDown SyndromePrenatal Diagnosis

Author keywords

aneuploidyfetusgynecologymedicineobstetricspregnancyprospective cohort studyrolling circle replicationtrisomy

Substances

Cell-Free Nucleic Acids

Authors and institutions

  • Department of Obstetrics and Gynecology, "Virgen de la Arrixaca" University Hospital, Murcia, Spain.
  • Department of Obstetrics and Gynecology, Pediatrics and Surgery, University of Murcia, Murcia, Spain.
  • Maternal-Fetal Medicine, Reproduction and Gynecology Research Group, Biomedical Research Institute of Murcia Pascual Parrilla-IMIB, Murcia, Spain.
  • Vanadis Diagnostics AB, a Revvity Inc Company, Sollentuna, Sweden.
  • Fetal Medicine Research Institute, King's College Hospital, London, UK.

ORCID profiles: Catalina De Paco Matallana, Javier Sánchez Romero, Miriam Pertegal, Juan Luis Delgado

Funding

  • Partial funding for this study was provided by Vanadis Diagnostics AB, a Revvity Inc. company, through the Foundation for Health Research and Training in the R…

Cite

APA

Matallana, C. P., Romero, J. S., Pertegal, M., Delgado, J. L., Ramfjord, E., & Nicolaides, K. H. (2026). First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study. Prenatal Diagnosis. https://doi.org/10.1002/pd.70260

Vancouver

Matallana CP, Romero JS, Pertegal M, Delgado JL, Ramfjord E, Nicolaides KH. First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study. Prenatal Diagnosis. 2026. doi:10.1002/pd.70260

BibTeX
@article{Matallana2026,
  author = {Matallana, Catalina De Paco and Romero, Javier Sánchez and Pertegal, Miriam and Delgado, Juan Luis and Ramfjord, Erica and Nicolaides, Kypros H},
  title = {First‐Trimester Cell‐Free DNA Screening for Common Trisomies Using Rolling‐Circle Amplification: A Prospective Study},
  journal = {Prenatal Diagnosis},
  year = {2026},
  doi = {10.1002/pd.70260}
}
Start for free →